Literature DB >> 2435685

Human mumps virus-specific cytotoxic T lymphocytes: quantitative analysis of HLA restriction.

K H Enssle, H Wagner, B Fleischer.   

Abstract

To obtain quantitative information about the use of HLA antigens as restriction element by antiviral cytotoxic T lymphocytes (CTL), we have analyzed precursors of human mumps virus-specific CTL by limiting dilution. CTL generated by restimulation of peripheral blood T lymphocytes with autologous mumps virus (MV)-infected stimulator cells were restricted by autologous HLA class I antigens, and derived from the T4-8+ population. They were specific for MV and did not lyse autologous target cells infected with other viruses. Frequencies of MV-specific CTL precursors ranged from 1/500 to 1/8000. HLA restriction was analyzed by split-well analysis of individual CTL colonies. CTL recognizing HLA-A or B antigens were unequally distributed: HLA-B7, -B13, and -B27 were found to function as predominant, in some cases as exclusive, restriction elements, whereas other antigens such as HLA-A24 were never or rarely used. In several combinations, there was no evidence for antigenic variants of HLA molecules as reason for the failure to be recognized. The proportion of CTL precursors recognizing HLA-A2 and -B8 seemed to be dependent on the presence or absence of "dominant" restriction elements. We conclude that CTL precursors recognizing certain virus-HLA combinations are preferentially expanded during an infection, but that low responsiveness to a given combination is not necessarily absolute.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435685     DOI: 10.1016/0198-8859(87)90011-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Selection for class II Mhc heterozygosity by parasites in subterranean mole rats.

Authors:  E Nevo; A Beiles
Journal:  Experientia       Date:  1992-05-15

2.  Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.

Authors:  I Bourgault; A Gomez; E Gomard; J P Levy
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

3.  Serological and biochemical identification of HLA-Aw33 subtypes.

Authors:  L P de Waal; H J Mesman; C P Engelfriet
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.

Authors:  K H Enssle; B Fleischer
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

5.  Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation.

Authors:  G J Boland; R J Hene; C Ververs; M A de Haan; G C de Gast
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

6.  Solid matrix-antibody-antigen complexes induce antigen-specific CD8+ cells that clear a persistent paramyxovirus infection.

Authors:  R E Randall; D F Young
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Limiting-dilution analysis of human CTL differentiation. Requirement for a lymphokine-mediated differentiation signal.

Authors:  D W Horohov; N I Stocks; J P Siegel
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.